A global, values-based, R&D-driven biopharmaceutical leader focused on innovation and patient care, with a strong U.S. presence and a legacy of over 235 years in advancing health solutions.
Notice Date
October 15, 2024
—
September 30, 2024
March 31, 2025
Cambridge
Massachusetts
Boston
